Home > Journals > European Journal of Physical and Rehabilitation Medicine > Past Issues > European Journal of Physical and Rehabilitation Medicine 2019 August;55(4) > European Journal of Physical and Rehabilitation Medicine 2019 August;55(4):418-23

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

SPECIAL ARTICLE   Freefree

European Journal of Physical and Rehabilitation Medicine 2019 August;55(4):418-23

DOI: 10.23736/S1973-9087.19.05570-9

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

European survey of management of patients with multidrug-resistant organisms in rehabilitation facilities

Aaron DOHERTY 1 , Sinéad McNICHOLAS 1, Helena BURGER 2, 3, Paolo BOLDRINI 4, Mark DELARGY 1, 5

1 National Rehabilitation Hospital, Dublin, Ireland; 2 University Rehabilitation Institute, Ljubljana, Slovenia; 3 Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; 4 Italian Society of Physical and Rehabilitation Medicine (SIMFER), Rome, Italy; 5 Royal College of Surgeons, Dublin, Ireland



BACKGROUND: Rehabilitation facilities have among the highest prevalence of multidrug-resistant organism (MDRO) colonization of any inpatient population. There is no formal consensus on how patients with MDROs should be managed in the rehabilitation setting.
AIM: The aim of this study was to assess how rehabilitation hospitals throughout Europe manage patients with MDROs, and the impact of MDRO carriage on outcomes.
DESIGN: Cross-sectional study.
SETTING: Online questionnaire distributed to European rehabilitation facilities.
POPULATION: European rehabilitation facilities.
METHODS: A Survey Monkey® questionnaire was designed and circulated to rehabilitation hospitals via the European Union of Medical Specialists, Physical and Rehabilitation Medicine Section.
RESULTS: Fifty-four responses were received of which 45 were suitable for analysis. Six out of 26 (23%) countries included in the study reported at least one rehabilitation facility with an estimated MDRO prevalence rate of 31% or higher. Screening of all patients on admission was always carried out in 33% (15 of 45) of facilities. Twenty-five of the 45 facilities (69%), aim to isolate, or cohort patients who have MDROs. Patients with MDROs wait longer for admission (36%, 16 of 45) and in the case of five hospitals admission is refused. Fifty-one percent (23 of 45) of facilities reported that colonization with an MDRO severely or moderately limits rehabilitation outcome.
CONCLUSIONS: Our research shows that many of the challenges posed by MDROs are common to facilities throughout Europe. We strongly recommend that all patients are screened for MDROs on admission. We stress that any negative impact of a patients MDRO status on their rehabilitation outcome must be minimized.
CLINICAL REHABILITATION IMPACT: Specific guidance on the management of rehabilitation patients with MDROs, would allow them to partake in a full rehabilitation program, while limiting the spread of MDROs.


KEY WORDS: Multiple drug resistance; Bacteria; Rehabilitation; Europe; Infection control; Cephalosporin resistance

top of page